Phase II Trial of Vorinostat in Recurrent Glioblastoma Multiforme: A North Central Cancer Treatment Group Study

Name: Work Video:
Duration: 3 min 30 s
Evanthia Galanis; Kurt A. Jaeckle; Matthew J. Maurer; Joel M. Reid; Matthew M. Ames; James S. Hardwick; John F. Reilly; Andrey Loboda; Michael Nebozhyn; Valeria R. Fantin; Victoria M. Richon; Bernd W. Scheithauer; Caterina Giannini; Patrick J. Flynn; Dennis F. Moore; James A. Zwiebel; Jan C. Buckner
{'id': 'https://openalex.org/W2171141282', 'doi': 'https://doi.org/10.1200/jco.2008.19.0694', 'title': 'Phase II Trial of Vorinostat in Recurrent Glioblastoma Multiforme: A North Central Cancer Treatment Group Study', 'display_name': 'Phase II Trial of Vorinostat in Recurrent Glioblastoma Multiforme: A North Central Cancer Treatment Group Study', 'publication_year': 2009, 'publication_date': '2009-03-24', 'ids': {'openalex': 'https://openalex.org/W2171141282', 'doi': 'https://doi.org/10.1200/jco.2008.19.0694', 'mag': '2171141282', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/19307505', 'pmcid': 'https://www.ncbi.nlm.nih.gov/pmc/articles/2669764'}, 'language': 'en', 'primary_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1200/jco.2008.19.0694', 'pdf_url': 'https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2008.19.0694?role=tab', 'source': {'id': 'https://openalex.org/S15137598', 'display_name': 'Journal of Clinical Oncology', 'issn_l': '0732-183X', 'issn': ['0732-183X', '1527-7755'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310315671', 'host_organization_name': 'Lippincott Williams & Wilkins', 'host_organization_lineage': ['https://openalex.org/P4310315671', 'https://openalex.org/P4310318547'], 'host_organization_lineage_names': ['Lippincott Williams & Wilkins', 'Wolters Kluwer'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': True, 'oa_status': 'bronze', 'oa_url': 'https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2008.19.0694?role=tab', 'any_repository_has_fulltext': True}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5017494786', 'display_name': 'Evanthia Galanis', 'orcid': 'https://orcid.org/0000-0001-8014-786X'}, 'institutions': [{'id': 'https://openalex.org/I2800547265', 'display_name': 'North Central Cancer Treatment Group', 'ror': 'https://ror.org/01a2yyy59', 'country_code': 'US', 'type': 'other', 'lineage': ['https://openalex.org/I2800547265']}, {'id': 'https://openalex.org/I4210146710', 'display_name': 'Mayo Clinic in Florida', 'ror': 'https://ror.org/03zzw1w08', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1330342723', 'https://openalex.org/I4210146710']}, {'id': 'https://openalex.org/I1330342723', 'display_name': 'Mayo Clinic', 'ror': 'https://ror.org/02qp3tb03', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1330342723']}, {'id': 'https://openalex.org/I1299303238', 'display_name': 'National Institutes of Health', 'ror': 'https://ror.org/01cwqze88', 'country_code': 'US', 'type': 'government', 'lineage': ['https://openalex.org/I1299022934', 'https://openalex.org/I1299303238']}, {'id': 'https://openalex.org/I4210120135', 'display_name': 'Metro-Minnesota Community Oncology Research Consortium', 'ror': 'https://ror.org/02vhx9606', 'country_code': 'US', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I4210120135']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Evanthia Galanis', 'raw_affiliation_strings': ['From the Mayo Clinic and North Central Cancer Treatment Group, Rochester, MN; Divisions of Medical Oncology and Biostatistics, Oncology Research, Department of Pathology, Mayo Clinic, Rochester; Metro Minnesota Community Clinical Oncology Program, St Louis Park, MN; Department of Neurology, Mayo Clinic, Jacksonville, FL; Merck, Whitehouse Station, NJ; Wichita Community Clinical Oncology Program, Wichita, KS; and National Institutes of Health, Cancer Therapy Evaluation Program, Bethesda, MD.'], 'affiliations': [{'raw_affiliation_string': 'From the Mayo Clinic and North Central Cancer Treatment Group, Rochester, MN; Divisions of Medical Oncology and Biostatistics, Oncology Research, Department of Pathology, Mayo Clinic, Rochester; Metro Minnesota Community Clinical Oncology Program, St Louis Park, MN; Department of Neurology, Mayo Clinic, Jacksonville, FL; Merck, Whitehouse Station, NJ; Wichita Community Clinical Oncology Program, Wichita, KS; and National Institutes of Health, Cancer Therapy Evaluation Program, Bethesda, MD.', 'institution_ids': ['https://openalex.org/I2800547265', 'https://openalex.org/I4210146710', 'https://openalex.org/I1330342723', 'https://openalex.org/I1299303238', 'https://openalex.org/I4210120135']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5023657472', 'display_name': 'Kurt A. Jaeckle', 'orcid': 'https://orcid.org/0000-0002-7827-463X'}, 'institutions': [{'id': 'https://openalex.org/I2800547265', 'display_name': 'North Central Cancer Treatment Group', 'ror': 'https://ror.org/01a2yyy59', 'country_code': 'US', 'type': 'other', 'lineage': ['https://openalex.org/I2800547265']}, {'id': 'https://openalex.org/I4210146710', 'display_name': 'Mayo Clinic in Florida', 'ror': 'https://ror.org/03zzw1w08', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1330342723', 'https://openalex.org/I4210146710']}, {'id': 'https://openalex.org/I1330342723', 'display_name': 'Mayo Clinic', 'ror': 'https://ror.org/02qp3tb03', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1330342723']}, {'id': 'https://openalex.org/I1299303238', 'display_name': 'National Institutes of Health', 'ror': 'https://ror.org/01cwqze88', 'country_code': 'US', 'type': 'government', 'lineage': ['https://openalex.org/I1299022934', 'https://openalex.org/I1299303238']}, {'id': 'https://openalex.org/I4210120135', 'display_name': 'Metro-Minnesota Community Oncology Research Consortium', 'ror': 'https://ror.org/02vhx9606', 'country_code': 'US', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I4210120135']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Kurt A. Jaeckle', 'raw_affiliation_strings': ['From the Mayo Clinic and North Central Cancer Treatment Group, Rochester, MN; Divisions of Medical Oncology and Biostatistics, Oncology Research, Department of Pathology, Mayo Clinic, Rochester; Metro Minnesota Community Clinical Oncology Program, St Louis Park, MN; Department of Neurology, Mayo Clinic, Jacksonville, FL; Merck, Whitehouse Station, NJ; Wichita Community Clinical Oncology Program, Wichita, KS; and National Institutes of Health, Cancer Therapy Evaluation Program, Bethesda, MD.'], 'affiliations': [{'raw_affiliation_string': 'From the Mayo Clinic and North Central Cancer Treatment Group, Rochester, MN; Divisions of Medical Oncology and Biostatistics, Oncology Research, Department of Pathology, Mayo Clinic, Rochester; Metro Minnesota Community Clinical Oncology Program, St Louis Park, MN; Department of Neurology, Mayo Clinic, Jacksonville, FL; Merck, Whitehouse Station, NJ; Wichita Community Clinical Oncology Program, Wichita, KS; and National Institutes of Health, Cancer Therapy Evaluation Program, Bethesda, MD.', 'institution_ids': ['https://openalex.org/I2800547265', 'https://openalex.org/I4210146710', 'https://openalex.org/I1330342723', 'https://openalex.org/I1299303238', 'https://openalex.org/I4210120135']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5059417970', 'display_name': 'Matthew J. Maurer', 'orcid': 'https://orcid.org/0000-0002-1867-0526'}, 'institutions': [{'id': 'https://openalex.org/I1299303238', 'display_name': 'National Institutes of Health', 'ror': 'https://ror.org/01cwqze88', 'country_code': 'US', 'type': 'government', 'lineage': ['https://openalex.org/I1299022934', 'https://openalex.org/I1299303238']}, {'id': 'https://openalex.org/I4210120135', 'display_name': 'Metro-Minnesota Community Oncology Research Consortium', 'ror': 'https://ror.org/02vhx9606', 'country_code': 'US', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I4210120135']}, {'id': 'https://openalex.org/I2800547265', 'display_name': 'North Central Cancer Treatment Group', 'ror': 'https://ror.org/01a2yyy59', 'country_code': 'US', 'type': 'other', 'lineage': ['https://openalex.org/I2800547265']}, {'id': 'https://openalex.org/I4210146710', 'display_name': 'Mayo Clinic in Florida', 'ror': 'https://ror.org/03zzw1w08', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1330342723', 'https://openalex.org/I4210146710']}, {'id': 'https://openalex.org/I1330342723', 'display_name': 'Mayo Clinic', 'ror': 'https://ror.org/02qp3tb03', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1330342723']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Matthew J. Maurer', 'raw_affiliation_strings': ['From the Mayo Clinic and North Central Cancer Treatment Group, Rochester, MN; Divisions of Medical Oncology and Biostatistics, Oncology Research, Department of Pathology, Mayo Clinic, Rochester; Metro Minnesota Community Clinical Oncology Program, St Louis Park, MN; Department of Neurology, Mayo Clinic, Jacksonville, FL; Merck, Whitehouse Station, NJ; Wichita Community Clinical Oncology Program, Wichita, KS; and National Institutes of Health, Cancer Therapy Evaluation Program, Bethesda, MD.'], 'affiliations': [{'raw_affiliation_string': 'From the Mayo Clinic and North Central Cancer Treatment Group, Rochester, MN; Divisions of Medical Oncology and Biostatistics, Oncology Research, Department of Pathology, Mayo Clinic, Rochester; Metro Minnesota Community Clinical Oncology Program, St Louis Park, MN; Department of Neurology, Mayo Clinic, Jacksonville, FL; Merck, Whitehouse Station, NJ; Wichita Community Clinical Oncology Program, Wichita, KS; and National Institutes of Health, Cancer Therapy Evaluation Program, Bethesda, MD.', 'institution_ids': ['https://openalex.org/I1299303238', 'https://openalex.org/I4210120135', 'https://openalex.org/I2800547265', 'https://openalex.org/I4210146710', 'https://openalex.org/I1330342723']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5027416118', 'display_name': 'Joel M. Reid', 'orcid': 'https://orcid.org/0000-0003-2872-3123'}, 'institutions': [{'id': 'https://openalex.org/I2800547265', 'display_name': 'North Central Cancer Treatment Group', 'ror': 'https://ror.org/01a2yyy59', 'country_code': 'US', 'type': 'other', 'lineage': ['https://openalex.org/I2800547265']}, {'id': 'https://openalex.org/I4210146710', 'display_name': 'Mayo Clinic in Florida', 'ror': 'https://ror.org/03zzw1w08', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1330342723', 'https://openalex.org/I4210146710']}, {'id': 'https://openalex.org/I1330342723', 'display_name': 'Mayo Clinic', 'ror': 'https://ror.org/02qp3tb03', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1330342723']}, {'id': 'https://openalex.org/I1299303238', 'display_name': 'National Institutes of Health', 'ror': 'https://ror.org/01cwqze88', 'country_code': 'US', 'type': 'government', 'lineage': ['https://openalex.org/I1299022934', 'https://openalex.org/I1299303238']}, {'id': 'https://openalex.org/I4210120135', 'display_name': 'Metro-Minnesota Community Oncology Research Consortium', 'ror': 'https://ror.org/02vhx9606', 'country_code': 'US', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I4210120135']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Joel M. Reid', 'raw_affiliation_strings': ['From the Mayo Clinic and North Central Cancer Treatment Group, Rochester, MN; Divisions of Medical Oncology and Biostatistics, Oncology Research, Department of Pathology, Mayo Clinic, Rochester; Metro Minnesota Community Clinical Oncology Program, St Louis Park, MN; Department of Neurology, Mayo Clinic, Jacksonville, FL; Merck, Whitehouse Station, NJ; Wichita Community Clinical Oncology Program, Wichita, KS; and National Institutes of Health, Cancer Therapy Evaluation Program, Bethesda, MD.'], 'affiliations': [{'raw_affiliation_string': 'From the Mayo Clinic and North Central Cancer Treatment Group, Rochester, MN; Divisions of Medical Oncology and Biostatistics, Oncology Research, Department of Pathology, Mayo Clinic, Rochester; Metro Minnesota Community Clinical Oncology Program, St Louis Park, MN; Department of Neurology, Mayo Clinic, Jacksonville, FL; Merck, Whitehouse Station, NJ; Wichita Community Clinical Oncology Program, Wichita, KS; and National Institutes of Health, Cancer Therapy Evaluation Program, Bethesda, MD.', 'institution_ids': ['https://openalex.org/I2800547265', 'https://openalex.org/I4210146710', 'https://openalex.org/I1330342723', 'https://openalex.org/I1299303238', 'https://openalex.org/I4210120135']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5066722006', 'display_name': 'Matthew M. Ames', 'orcid': 'https://orcid.org/0000-0003-3652-209X'}, 'institutions': [{'id': 'https://openalex.org/I4210146710', 'display_name': 'Mayo Clinic in Florida', 'ror': 'https://ror.org/03zzw1w08', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1330342723', 'https://openalex.org/I4210146710']}, {'id': 'https://openalex.org/I1330342723', 'display_name': 'Mayo Clinic', 'ror': 'https://ror.org/02qp3tb03', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1330342723']}, {'id': 'https://openalex.org/I1299303238', 'display_name': 'National Institutes of Health', 'ror': 'https://ror.org/01cwqze88', 'country_code': 'US', 'type': 'government', 'lineage': ['https://openalex.org/I1299022934', 'https://openalex.org/I1299303238']}, {'id': 'https://openalex.org/I2800547265', 'display_name': 'North Central Cancer Treatment Group', 'ror': 'https://ror.org/01a2yyy59', 'country_code': 'US', 'type': 'other', 'lineage': ['https://openalex.org/I2800547265']}, {'id': 'https://openalex.org/I4210120135', 'display_name': 'Metro-Minnesota Community Oncology Research Consortium', 'ror': 'https://ror.org/02vhx9606', 'country_code': 'US', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I4210120135']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Matthew M. Ames', 'raw_affiliation_strings': ['From the Mayo Clinic and North Central Cancer Treatment Group, Rochester, MN; Divisions of Medical Oncology and Biostatistics, Oncology Research, Department of Pathology, Mayo Clinic, Rochester; Metro Minnesota Community Clinical Oncology Program, St Louis Park, MN; Department of Neurology, Mayo Clinic, Jacksonville, FL; Merck, Whitehouse Station, NJ; Wichita Community Clinical Oncology Program, Wichita, KS; and National Institutes of Health, Cancer Therapy Evaluation Program, Bethesda, MD.'], 'affiliations': [{'raw_affiliation_string': 'From the Mayo Clinic and North Central Cancer Treatment Group, Rochester, MN; Divisions of Medical Oncology and Biostatistics, Oncology Research, Department of Pathology, Mayo Clinic, Rochester; Metro Minnesota Community Clinical Oncology Program, St Louis Park, MN; Department of Neurology, Mayo Clinic, Jacksonville, FL; Merck, Whitehouse Station, NJ; Wichita Community Clinical Oncology Program, Wichita, KS; and National Institutes of Health, Cancer Therapy Evaluation Program, Bethesda, MD.', 'institution_ids': ['https://openalex.org/I4210146710', 'https://openalex.org/I1330342723', 'https://openalex.org/I1299303238', 'https://openalex.org/I2800547265', 'https://openalex.org/I4210120135']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5103498404', 'display_name': 'James S. Hardwick', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I1330342723', 'display_name': 'Mayo Clinic', 'ror': 'https://ror.org/02qp3tb03', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1330342723']}, {'id': 'https://openalex.org/I2800547265', 'display_name': 'North Central Cancer Treatment Group', 'ror': 'https://ror.org/01a2yyy59', 'country_code': 'US', 'type': 'other', 'lineage': ['https://openalex.org/I2800547265']}, {'id': 'https://openalex.org/I4210146710', 'display_name': 'Mayo Clinic in Florida', 'ror': 'https://ror.org/03zzw1w08', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1330342723', 'https://openalex.org/I4210146710']}, {'id': 'https://openalex.org/I1299303238', 'display_name': 'National Institutes of Health', 'ror': 'https://ror.org/01cwqze88', 'country_code': 'US', 'type': 'government', 'lineage': ['https://openalex.org/I1299022934', 'https://openalex.org/I1299303238']}, {'id': 'https://openalex.org/I4210120135', 'display_name': 'Metro-Minnesota Community Oncology Research Consortium', 'ror': 'https://ror.org/02vhx9606', 'country_code': 'US', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I4210120135']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'James S. Hardwick', 'raw_affiliation_strings': ['From the Mayo Clinic and North Central Cancer Treatment Group, Rochester, MN; Divisions of Medical Oncology and Biostatistics, Oncology Research, Department of Pathology, Mayo Clinic, Rochester; Metro Minnesota Community Clinical Oncology Program, St Louis Park, MN; Department of Neurology, Mayo Clinic, Jacksonville, FL; Merck, Whitehouse Station, NJ; Wichita Community Clinical Oncology Program, Wichita, KS; and National Institutes of Health, Cancer Therapy Evaluation Program, Bethesda, MD.'], 'affiliations': [{'raw_affiliation_string': 'From the Mayo Clinic and North Central Cancer Treatment Group, Rochester, MN; Divisions of Medical Oncology and Biostatistics, Oncology Research, Department of Pathology, Mayo Clinic, Rochester; Metro Minnesota Community Clinical Oncology Program, St Louis Park, MN; Department of Neurology, Mayo Clinic, Jacksonville, FL; Merck, Whitehouse Station, NJ; Wichita Community Clinical Oncology Program, Wichita, KS; and National Institutes of Health, Cancer Therapy Evaluation Program, Bethesda, MD.', 'institution_ids': ['https://openalex.org/I1330342723', 'https://openalex.org/I2800547265', 'https://openalex.org/I4210146710', 'https://openalex.org/I1299303238', 'https://openalex.org/I4210120135']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5029871230', 'display_name': 'John F. Reilly', 'orcid': 'https://orcid.org/0000-0002-7164-0246'}, 'institutions': [{'id': 'https://openalex.org/I2800547265', 'display_name': 'North Central Cancer Treatment Group', 'ror': 'https://ror.org/01a2yyy59', 'country_code': 'US', 'type': 'other', 'lineage': ['https://openalex.org/I2800547265']}, {'id': 'https://openalex.org/I4210146710', 'display_name': 'Mayo Clinic in Florida', 'ror': 'https://ror.org/03zzw1w08', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1330342723', 'https://openalex.org/I4210146710']}, {'id': 'https://openalex.org/I1330342723', 'display_name': 'Mayo Clinic', 'ror': 'https://ror.org/02qp3tb03', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1330342723']}, {'id': 'https://openalex.org/I1299303238', 'display_name': 'National Institutes of Health', 'ror': 'https://ror.org/01cwqze88', 'country_code': 'US', 'type': 'government', 'lineage': ['https://openalex.org/I1299022934', 'https://openalex.org/I1299303238']}, {'id': 'https://openalex.org/I4210120135', 'display_name': 'Metro-Minnesota Community Oncology Research Consortium', 'ror': 'https://ror.org/02vhx9606', 'country_code': 'US', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I4210120135']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'John F. Reilly', 'raw_affiliation_strings': ['From the Mayo Clinic and North Central Cancer Treatment Group, Rochester, MN; Divisions of Medical Oncology and Biostatistics, Oncology Research, Department of Pathology, Mayo Clinic, Rochester; Metro Minnesota Community Clinical Oncology Program, St Louis Park, MN; Department of Neurology, Mayo Clinic, Jacksonville, FL; Merck, Whitehouse Station, NJ; Wichita Community Clinical Oncology Program, Wichita, KS; and National Institutes of Health, Cancer Therapy Evaluation Program, Bethesda, MD.'], 'affiliations': [{'raw_affiliation_string': 'From the Mayo Clinic and North Central Cancer Treatment Group, Rochester, MN; Divisions of Medical Oncology and Biostatistics, Oncology Research, Department of Pathology, Mayo Clinic, Rochester; Metro Minnesota Community Clinical Oncology Program, St Louis Park, MN; Department of Neurology, Mayo Clinic, Jacksonville, FL; Merck, Whitehouse Station, NJ; Wichita Community Clinical Oncology Program, Wichita, KS; and National Institutes of Health, Cancer Therapy Evaluation Program, Bethesda, MD.', 'institution_ids': ['https://openalex.org/I2800547265', 'https://openalex.org/I4210146710', 'https://openalex.org/I1330342723', 'https://openalex.org/I1299303238', 'https://openalex.org/I4210120135']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5060841115', 'display_name': 'Andrey Loboda', 'orcid': 'https://orcid.org/0000-0003-4239-184X'}, 'institutions': [{'id': 'https://openalex.org/I2800547265', 'display_name': 'North Central Cancer Treatment Group', 'ror': 'https://ror.org/01a2yyy59', 'country_code': 'US', 'type': 'other', 'lineage': ['https://openalex.org/I2800547265']}, {'id': 'https://openalex.org/I4210146710', 'display_name': 'Mayo Clinic in Florida', 'ror': 'https://ror.org/03zzw1w08', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1330342723', 'https://openalex.org/I4210146710']}, {'id': 'https://openalex.org/I1330342723', 'display_name': 'Mayo Clinic', 'ror': 'https://ror.org/02qp3tb03', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1330342723']}, {'id': 'https://openalex.org/I1299303238', 'display_name': 'National Institutes of Health', 'ror': 'https://ror.org/01cwqze88', 'country_code': 'US', 'type': 'government', 'lineage': ['https://openalex.org/I1299022934', 'https://openalex.org/I1299303238']}, {'id': 'https://openalex.org/I4210120135', 'display_name': 'Metro-Minnesota Community Oncology Research Consortium', 'ror': 'https://ror.org/02vhx9606', 'country_code': 'US', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I4210120135']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Andrey Loboda', 'raw_affiliation_strings': ['From the Mayo Clinic and North Central Cancer Treatment Group, Rochester, MN; Divisions of Medical Oncology and Biostatistics, Oncology Research, Department of Pathology, Mayo Clinic, Rochester; Metro Minnesota Community Clinical Oncology Program, St Louis Park, MN; Department of Neurology, Mayo Clinic, Jacksonville, FL; Merck, Whitehouse Station, NJ; Wichita Community Clinical Oncology Program, Wichita, KS; and National Institutes of Health, Cancer Therapy Evaluation Program, Bethesda, MD.'], 'affiliations': [{'raw_affiliation_string': 'From the Mayo Clinic and North Central Cancer Treatment Group, Rochester, MN; Divisions of Medical Oncology and Biostatistics, Oncology Research, Department of Pathology, Mayo Clinic, Rochester; Metro Minnesota Community Clinical Oncology Program, St Louis Park, MN; Department of Neurology, Mayo Clinic, Jacksonville, FL; Merck, Whitehouse Station, NJ; Wichita Community Clinical Oncology Program, Wichita, KS; and National Institutes of Health, Cancer Therapy Evaluation Program, Bethesda, MD.', 'institution_ids': ['https://openalex.org/I2800547265', 'https://openalex.org/I4210146710', 'https://openalex.org/I1330342723', 'https://openalex.org/I1299303238', 'https://openalex.org/I4210120135']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5054654521', 'display_name': 'Michael Nebozhyn', 'orcid': 'https://orcid.org/0000-0001-8835-7714'}, 'institutions': [{'id': 'https://openalex.org/I2800547265', 'display_name': 'North Central Cancer Treatment Group', 'ror': 'https://ror.org/01a2yyy59', 'country_code': 'US', 'type': 'other', 'lineage': ['https://openalex.org/I2800547265']}, {'id': 'https://openalex.org/I4210146710', 'display_name': 'Mayo Clinic in Florida', 'ror': 'https://ror.org/03zzw1w08', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1330342723', 'https://openalex.org/I4210146710']}, {'id': 'https://openalex.org/I1299303238', 'display_name': 'National Institutes of Health', 'ror': 'https://ror.org/01cwqze88', 'country_code': 'US', 'type': 'government', 'lineage': ['https://openalex.org/I1299022934', 'https://openalex.org/I1299303238']}, {'id': 'https://openalex.org/I4210120135', 'display_name': 'Metro-Minnesota Community Oncology Research Consortium', 'ror': 'https://ror.org/02vhx9606', 'country_code': 'US', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I4210120135']}, {'id': 'https://openalex.org/I1330342723', 'display_name': 'Mayo Clinic', 'ror': 'https://ror.org/02qp3tb03', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1330342723']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Michael Nebozhyn', 'raw_affiliation_strings': ['From the Mayo Clinic and North Central Cancer Treatment Group, Rochester, MN; Divisions of Medical Oncology and Biostatistics, Oncology Research, Department of Pathology, Mayo Clinic, Rochester; Metro Minnesota Community Clinical Oncology Program, St Louis Park, MN; Department of Neurology, Mayo Clinic, Jacksonville, FL; Merck, Whitehouse Station, NJ; Wichita Community Clinical Oncology Program, Wichita, KS; and National Institutes of Health, Cancer Therapy Evaluation Program, Bethesda, MD.'], 'affiliations': [{'raw_affiliation_string': 'From the Mayo Clinic and North Central Cancer Treatment Group, Rochester, MN; Divisions of Medical Oncology and Biostatistics, Oncology Research, Department of Pathology, Mayo Clinic, Rochester; Metro Minnesota Community Clinical Oncology Program, St Louis Park, MN; Department of Neurology, Mayo Clinic, Jacksonville, FL; Merck, Whitehouse Station, NJ; Wichita Community Clinical Oncology Program, Wichita, KS; and National Institutes of Health, Cancer Therapy Evaluation Program, Bethesda, MD.', 'institution_ids': ['https://openalex.org/I2800547265', 'https://openalex.org/I4210146710', 'https://openalex.org/I1299303238', 'https://openalex.org/I4210120135', 'https://openalex.org/I1330342723']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5059897477', 'display_name': 'Valeria R. Fantin', 'orcid': 'https://orcid.org/0009-0005-8328-0152'}, 'institutions': [{'id': 'https://openalex.org/I1299303238', 'display_name': 'National Institutes of Health', 'ror': 'https://ror.org/01cwqze88', 'country_code': 'US', 'type': 'government', 'lineage': ['https://openalex.org/I1299022934', 'https://openalex.org/I1299303238']}, {'id': 'https://openalex.org/I4210120135', 'display_name': 'Metro-Minnesota Community Oncology Research Consortium', 'ror': 'https://ror.org/02vhx9606', 'country_code': 'US', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I4210120135']}, {'id': 'https://openalex.org/I2800547265', 'display_name': 'North Central Cancer Treatment Group', 'ror': 'https://ror.org/01a2yyy59', 'country_code': 'US', 'type': 'other', 'lineage': ['https://openalex.org/I2800547265']}, {'id': 'https://openalex.org/I4210146710', 'display_name': 'Mayo Clinic in Florida', 'ror': 'https://ror.org/03zzw1w08', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1330342723', 'https://openalex.org/I4210146710']}, {'id': 'https://openalex.org/I1330342723', 'display_name': 'Mayo Clinic', 'ror': 'https://ror.org/02qp3tb03', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1330342723']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Valeria R. Fantin', 'raw_affiliation_strings': ['From the Mayo Clinic and North Central Cancer Treatment Group, Rochester, MN; Divisions of Medical Oncology and Biostatistics, Oncology Research, Department of Pathology, Mayo Clinic, Rochester; Metro Minnesota Community Clinical Oncology Program, St Louis Park, MN; Department of Neurology, Mayo Clinic, Jacksonville, FL; Merck, Whitehouse Station, NJ; Wichita Community Clinical Oncology Program, Wichita, KS; and National Institutes of Health, Cancer Therapy Evaluation Program, Bethesda, MD.'], 'affiliations': [{'raw_affiliation_string': 'From the Mayo Clinic and North Central Cancer Treatment Group, Rochester, MN; Divisions of Medical Oncology and Biostatistics, Oncology Research, Department of Pathology, Mayo Clinic, Rochester; Metro Minnesota Community Clinical Oncology Program, St Louis Park, MN; Department of Neurology, Mayo Clinic, Jacksonville, FL; Merck, Whitehouse Station, NJ; Wichita Community Clinical Oncology Program, Wichita, KS; and National Institutes of Health, Cancer Therapy Evaluation Program, Bethesda, MD.', 'institution_ids': ['https://openalex.org/I1299303238', 'https://openalex.org/I4210120135', 'https://openalex.org/I2800547265', 'https://openalex.org/I4210146710', 'https://openalex.org/I1330342723']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5027363771', 'display_name': 'Victoria M. Richon', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I2800547265', 'display_name': 'North Central Cancer Treatment Group', 'ror': 'https://ror.org/01a2yyy59', 'country_code': 'US', 'type': 'other', 'lineage': ['https://openalex.org/I2800547265']}, {'id': 'https://openalex.org/I4210146710', 'display_name': 'Mayo Clinic in Florida', 'ror': 'https://ror.org/03zzw1w08', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1330342723', 'https://openalex.org/I4210146710']}, {'id': 'https://openalex.org/I1330342723', 'display_name': 'Mayo Clinic', 'ror': 'https://ror.org/02qp3tb03', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1330342723']}, {'id': 'https://openalex.org/I1299303238', 'display_name': 'National Institutes of Health', 'ror': 'https://ror.org/01cwqze88', 'country_code': 'US', 'type': 'government', 'lineage': ['https://openalex.org/I1299022934', 'https://openalex.org/I1299303238']}, {'id': 'https://openalex.org/I4210120135', 'display_name': 'Metro-Minnesota Community Oncology Research Consortium', 'ror': 'https://ror.org/02vhx9606', 'country_code': 'US', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I4210120135']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Victoria M. Richon', 'raw_affiliation_strings': ['From the Mayo Clinic and North Central Cancer Treatment Group, Rochester, MN; Divisions of Medical Oncology and Biostatistics, Oncology Research, Department of Pathology, Mayo Clinic, Rochester; Metro Minnesota Community Clinical Oncology Program, St Louis Park, MN; Department of Neurology, Mayo Clinic, Jacksonville, FL; Merck, Whitehouse Station, NJ; Wichita Community Clinical Oncology Program, Wichita, KS; and National Institutes of Health, Cancer Therapy Evaluation Program, Bethesda, MD.'], 'affiliations': [{'raw_affiliation_string': 'From the Mayo Clinic and North Central Cancer Treatment Group, Rochester, MN; Divisions of Medical Oncology and Biostatistics, Oncology Research, Department of Pathology, Mayo Clinic, Rochester; Metro Minnesota Community Clinical Oncology Program, St Louis Park, MN; Department of Neurology, Mayo Clinic, Jacksonville, FL; Merck, Whitehouse Station, NJ; Wichita Community Clinical Oncology Program, Wichita, KS; and National Institutes of Health, Cancer Therapy Evaluation Program, Bethesda, MD.', 'institution_ids': ['https://openalex.org/I2800547265', 'https://openalex.org/I4210146710', 'https://openalex.org/I1330342723', 'https://openalex.org/I1299303238', 'https://openalex.org/I4210120135']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5110883848', 'display_name': 'Bernd W. Scheithauer', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210146710', 'display_name': 'Mayo Clinic in Florida', 'ror': 'https://ror.org/03zzw1w08', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1330342723', 'https://openalex.org/I4210146710']}, {'id': 'https://openalex.org/I1330342723', 'display_name': 'Mayo Clinic', 'ror': 'https://ror.org/02qp3tb03', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1330342723']}, {'id': 'https://openalex.org/I1299303238', 'display_name': 'National Institutes of Health', 'ror': 'https://ror.org/01cwqze88', 'country_code': 'US', 'type': 'government', 'lineage': ['https://openalex.org/I1299022934', 'https://openalex.org/I1299303238']}, {'id': 'https://openalex.org/I4210120135', 'display_name': 'Metro-Minnesota Community Oncology Research Consortium', 'ror': 'https://ror.org/02vhx9606', 'country_code': 'US', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I4210120135']}, {'id': 'https://openalex.org/I2800547265', 'display_name': 'North Central Cancer Treatment Group', 'ror': 'https://ror.org/01a2yyy59', 'country_code': 'US', 'type': 'other', 'lineage': ['https://openalex.org/I2800547265']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Bernd Scheithauer', 'raw_affiliation_strings': ['From the Mayo Clinic and North Central Cancer Treatment Group, Rochester, MN; Divisions of Medical Oncology and Biostatistics, Oncology Research, Department of Pathology, Mayo Clinic, Rochester; Metro Minnesota Community Clinical Oncology Program, St Louis Park, MN; Department of Neurology, Mayo Clinic, Jacksonville, FL; Merck, Whitehouse Station, NJ; Wichita Community Clinical Oncology Program, Wichita, KS; and National Institutes of Health, Cancer Therapy Evaluation Program, Bethesda, MD.'], 'affiliations': [{'raw_affiliation_string': 'From the Mayo Clinic and North Central Cancer Treatment Group, Rochester, MN; Divisions of Medical Oncology and Biostatistics, Oncology Research, Department of Pathology, Mayo Clinic, Rochester; Metro Minnesota Community Clinical Oncology Program, St Louis Park, MN; Department of Neurology, Mayo Clinic, Jacksonville, FL; Merck, Whitehouse Station, NJ; Wichita Community Clinical Oncology Program, Wichita, KS; and National Institutes of Health, Cancer Therapy Evaluation Program, Bethesda, MD.', 'institution_ids': ['https://openalex.org/I4210146710', 'https://openalex.org/I1330342723', 'https://openalex.org/I1299303238', 'https://openalex.org/I4210120135', 'https://openalex.org/I2800547265']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5069689120', 'display_name': 'Caterina Giannini', 'orcid': 'https://orcid.org/0000-0003-2757-6782'}, 'institutions': [{'id': 'https://openalex.org/I1330342723', 'display_name': 'Mayo Clinic', 'ror': 'https://ror.org/02qp3tb03', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1330342723']}, {'id': 'https://openalex.org/I1299303238', 'display_name': 'National Institutes of Health', 'ror': 'https://ror.org/01cwqze88', 'country_code': 'US', 'type': 'government', 'lineage': ['https://openalex.org/I1299022934', 'https://openalex.org/I1299303238']}, {'id': 'https://openalex.org/I4210120135', 'display_name': 'Metro-Minnesota Community Oncology Research Consortium', 'ror': 'https://ror.org/02vhx9606', 'country_code': 'US', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I4210120135']}, {'id': 'https://openalex.org/I2800547265', 'display_name': 'North Central Cancer Treatment Group', 'ror': 'https://ror.org/01a2yyy59', 'country_code': 'US', 'type': 'other', 'lineage': ['https://openalex.org/I2800547265']}, {'id': 'https://openalex.org/I4210146710', 'display_name': 'Mayo Clinic in Florida', 'ror': 'https://ror.org/03zzw1w08', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1330342723', 'https://openalex.org/I4210146710']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Caterina Giannini', 'raw_affiliation_strings': ['From the Mayo Clinic and North Central Cancer Treatment Group, Rochester, MN; Divisions of Medical Oncology and Biostatistics, Oncology Research, Department of Pathology, Mayo Clinic, Rochester; Metro Minnesota Community Clinical Oncology Program, St Louis Park, MN; Department of Neurology, Mayo Clinic, Jacksonville, FL; Merck, Whitehouse Station, NJ; Wichita Community Clinical Oncology Program, Wichita, KS; and National Institutes of Health, Cancer Therapy Evaluation Program, Bethesda, MD.'], 'affiliations': [{'raw_affiliation_string': 'From the Mayo Clinic and North Central Cancer Treatment Group, Rochester, MN; Divisions of Medical Oncology and Biostatistics, Oncology Research, Department of Pathology, Mayo Clinic, Rochester; Metro Minnesota Community Clinical Oncology Program, St Louis Park, MN; Department of Neurology, Mayo Clinic, Jacksonville, FL; Merck, Whitehouse Station, NJ; Wichita Community Clinical Oncology Program, Wichita, KS; and National Institutes of Health, Cancer Therapy Evaluation Program, Bethesda, MD.', 'institution_ids': ['https://openalex.org/I1330342723', 'https://openalex.org/I1299303238', 'https://openalex.org/I4210120135', 'https://openalex.org/I2800547265', 'https://openalex.org/I4210146710']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5012465182', 'display_name': 'Patrick J. Flynn', 'orcid': 'https://orcid.org/0000-0001-6516-8021'}, 'institutions': [{'id': 'https://openalex.org/I4210146710', 'display_name': 'Mayo Clinic in Florida', 'ror': 'https://ror.org/03zzw1w08', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1330342723', 'https://openalex.org/I4210146710']}, {'id': 'https://openalex.org/I1299303238', 'display_name': 'National Institutes of Health', 'ror': 'https://ror.org/01cwqze88', 'country_code': 'US', 'type': 'government', 'lineage': ['https://openalex.org/I1299022934', 'https://openalex.org/I1299303238']}, {'id': 'https://openalex.org/I2800547265', 'display_name': 'North Central Cancer Treatment Group', 'ror': 'https://ror.org/01a2yyy59', 'country_code': 'US', 'type': 'other', 'lineage': ['https://openalex.org/I2800547265']}, {'id': 'https://openalex.org/I1330342723', 'display_name': 'Mayo Clinic', 'ror': 'https://ror.org/02qp3tb03', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1330342723']}, {'id': 'https://openalex.org/I4210120135', 'display_name': 'Metro-Minnesota Community Oncology Research Consortium', 'ror': 'https://ror.org/02vhx9606', 'country_code': 'US', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I4210120135']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Patrick J. Flynn', 'raw_affiliation_strings': ['From the Mayo Clinic and North Central Cancer Treatment Group, Rochester, MN; Divisions of Medical Oncology and Biostatistics, Oncology Research, Department of Pathology, Mayo Clinic, Rochester; Metro Minnesota Community Clinical Oncology Program, St Louis Park, MN; Department of Neurology, Mayo Clinic, Jacksonville, FL; Merck, Whitehouse Station, NJ; Wichita Community Clinical Oncology Program, Wichita, KS; and National Institutes of Health, Cancer Therapy Evaluation Program, Bethesda, MD.'], 'affiliations': [{'raw_affiliation_string': 'From the Mayo Clinic and North Central Cancer Treatment Group, Rochester, MN; Divisions of Medical Oncology and Biostatistics, Oncology Research, Department of Pathology, Mayo Clinic, Rochester; Metro Minnesota Community Clinical Oncology Program, St Louis Park, MN; Department of Neurology, Mayo Clinic, Jacksonville, FL; Merck, Whitehouse Station, NJ; Wichita Community Clinical Oncology Program, Wichita, KS; and National Institutes of Health, Cancer Therapy Evaluation Program, Bethesda, MD.', 'institution_ids': ['https://openalex.org/I4210146710', 'https://openalex.org/I1299303238', 'https://openalex.org/I2800547265', 'https://openalex.org/I1330342723', 'https://openalex.org/I4210120135']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5103485014', 'display_name': 'Dennis F. Moore', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I1330342723', 'display_name': 'Mayo Clinic', 'ror': 'https://ror.org/02qp3tb03', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1330342723']}, {'id': 'https://openalex.org/I4210120135', 'display_name': 'Metro-Minnesota Community Oncology Research Consortium', 'ror': 'https://ror.org/02vhx9606', 'country_code': 'US', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I4210120135']}, {'id': 'https://openalex.org/I2800547265', 'display_name': 'North Central Cancer Treatment Group', 'ror': 'https://ror.org/01a2yyy59', 'country_code': 'US', 'type': 'other', 'lineage': ['https://openalex.org/I2800547265']}, {'id': 'https://openalex.org/I4210146710', 'display_name': 'Mayo Clinic in Florida', 'ror': 'https://ror.org/03zzw1w08', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1330342723', 'https://openalex.org/I4210146710']}, {'id': 'https://openalex.org/I1299303238', 'display_name': 'National Institutes of Health', 'ror': 'https://ror.org/01cwqze88', 'country_code': 'US', 'type': 'government', 'lineage': ['https://openalex.org/I1299022934', 'https://openalex.org/I1299303238']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Dennis F. Moore', 'raw_affiliation_strings': ['From the Mayo Clinic and North Central Cancer Treatment Group, Rochester, MN; Divisions of Medical Oncology and Biostatistics, Oncology Research, Department of Pathology, Mayo Clinic, Rochester; Metro Minnesota Community Clinical Oncology Program, St Louis Park, MN; Department of Neurology, Mayo Clinic, Jacksonville, FL; Merck, Whitehouse Station, NJ; Wichita Community Clinical Oncology Program, Wichita, KS; and National Institutes of Health, Cancer Therapy Evaluation Program, Bethesda, MD.'], 'affiliations': [{'raw_affiliation_string': 'From the Mayo Clinic and North Central Cancer Treatment Group, Rochester, MN; Divisions of Medical Oncology and Biostatistics, Oncology Research, Department of Pathology, Mayo Clinic, Rochester; Metro Minnesota Community Clinical Oncology Program, St Louis Park, MN; Department of Neurology, Mayo Clinic, Jacksonville, FL; Merck, Whitehouse Station, NJ; Wichita Community Clinical Oncology Program, Wichita, KS; and National Institutes of Health, Cancer Therapy Evaluation Program, Bethesda, MD.', 'institution_ids': ['https://openalex.org/I1330342723', 'https://openalex.org/I4210120135', 'https://openalex.org/I2800547265', 'https://openalex.org/I4210146710', 'https://openalex.org/I1299303238']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5033174879', 'display_name': 'James A. Zwiebel', 'orcid': 'https://orcid.org/0000-0003-4455-8789'}, 'institutions': [{'id': 'https://openalex.org/I1299303238', 'display_name': 'National Institutes of Health', 'ror': 'https://ror.org/01cwqze88', 'country_code': 'US', 'type': 'government', 'lineage': ['https://openalex.org/I1299022934', 'https://openalex.org/I1299303238']}, {'id': 'https://openalex.org/I4210120135', 'display_name': 'Metro-Minnesota Community Oncology Research Consortium', 'ror': 'https://ror.org/02vhx9606', 'country_code': 'US', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I4210120135']}, {'id': 'https://openalex.org/I2800547265', 'display_name': 'North Central Cancer Treatment Group', 'ror': 'https://ror.org/01a2yyy59', 'country_code': 'US', 'type': 'other', 'lineage': ['https://openalex.org/I2800547265']}, {'id': 'https://openalex.org/I4210146710', 'display_name': 'Mayo Clinic in Florida', 'ror': 'https://ror.org/03zzw1w08', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1330342723', 'https://openalex.org/I4210146710']}, {'id': 'https://openalex.org/I1330342723', 'display_name': 'Mayo Clinic', 'ror': 'https://ror.org/02qp3tb03', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1330342723']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'James Zwiebel', 'raw_affiliation_strings': ['From the Mayo Clinic and North Central Cancer Treatment Group, Rochester, MN; Divisions of Medical Oncology and Biostatistics, Oncology Research, Department of Pathology, Mayo Clinic, Rochester; Metro Minnesota Community Clinical Oncology Program, St Louis Park, MN; Department of Neurology, Mayo Clinic, Jacksonville, FL; Merck, Whitehouse Station, NJ; Wichita Community Clinical Oncology Program, Wichita, KS; and National Institutes of Health, Cancer Therapy Evaluation Program, Bethesda, MD.'], 'affiliations': [{'raw_affiliation_string': 'From the Mayo Clinic and North Central Cancer Treatment Group, Rochester, MN; Divisions of Medical Oncology and Biostatistics, Oncology Research, Department of Pathology, Mayo Clinic, Rochester; Metro Minnesota Community Clinical Oncology Program, St Louis Park, MN; Department of Neurology, Mayo Clinic, Jacksonville, FL; Merck, Whitehouse Station, NJ; Wichita Community Clinical Oncology Program, Wichita, KS; and National Institutes of Health, Cancer Therapy Evaluation Program, Bethesda, MD.', 'institution_ids': ['https://openalex.org/I1299303238', 'https://openalex.org/I4210120135', 'https://openalex.org/I2800547265', 'https://openalex.org/I4210146710', 'https://openalex.org/I1330342723']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5034104319', 'display_name': 'Jan C. Buckner', 'orcid': 'https://orcid.org/0000-0002-8688-266X'}, 'institutions': [{'id': 'https://openalex.org/I2800547265', 'display_name': 'North Central Cancer Treatment Group', 'ror': 'https://ror.org/01a2yyy59', 'country_code': 'US', 'type': 'other', 'lineage': ['https://openalex.org/I2800547265']}, {'id': 'https://openalex.org/I4210146710', 'display_name': 'Mayo Clinic in Florida', 'ror': 'https://ror.org/03zzw1w08', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1330342723', 'https://openalex.org/I4210146710']}, {'id': 'https://openalex.org/I1330342723', 'display_name': 'Mayo Clinic', 'ror': 'https://ror.org/02qp3tb03', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1330342723']}, {'id': 'https://openalex.org/I1299303238', 'display_name': 'National Institutes of Health', 'ror': 'https://ror.org/01cwqze88', 'country_code': 'US', 'type': 'government', 'lineage': ['https://openalex.org/I1299022934', 'https://openalex.org/I1299303238']}, {'id': 'https://openalex.org/I4210120135', 'display_name': 'Metro-Minnesota Community Oncology Research Consortium', 'ror': 'https://ror.org/02vhx9606', 'country_code': 'US', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I4210120135']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Jan C. Buckner', 'raw_affiliation_strings': ['From the Mayo Clinic and North Central Cancer Treatment Group, Rochester, MN; Divisions of Medical Oncology and Biostatistics, Oncology Research, Department of Pathology, Mayo Clinic, Rochester; Metro Minnesota Community Clinical Oncology Program, St Louis Park, MN; Department of Neurology, Mayo Clinic, Jacksonville, FL; Merck, Whitehouse Station, NJ; Wichita Community Clinical Oncology Program, Wichita, KS; and National Institutes of Health, Cancer Therapy Evaluation Program, Bethesda, MD.'], 'affiliations': [{'raw_affiliation_string': 'From the Mayo Clinic and North Central Cancer Treatment Group, Rochester, MN; Divisions of Medical Oncology and Biostatistics, Oncology Research, Department of Pathology, Mayo Clinic, Rochester; Metro Minnesota Community Clinical Oncology Program, St Louis Park, MN; Department of Neurology, Mayo Clinic, Jacksonville, FL; Merck, Whitehouse Station, NJ; Wichita Community Clinical Oncology Program, Wichita, KS; and National Institutes of Health, Cancer Therapy Evaluation Program, Bethesda, MD.', 'institution_ids': ['https://openalex.org/I2800547265', 'https://openalex.org/I4210146710', 'https://openalex.org/I1330342723', 'https://openalex.org/I1299303238', 'https://openalex.org/I4210120135']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 5, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 13.819, 'has_fulltext': True, 'fulltext_origin': 'ngrams', 'cited_by_count': 335, 'citation_normalized_percentile': {'value': 0.999984, 'is_in_top_1_percent': True, 'is_in_top_10_percent': True}, 'cited_by_percentile_year': {'min': 99, 'max': 100}, 'biblio': {'volume': '27', 'issue': '12', 'first_page': '2052', 'last_page': '2058'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T11736', 'display_name': 'Histone Deacetylase Inhibitors Research', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, 'topics': [{'id': 'https://openalex.org/T11736', 'display_name': 'Histone Deacetylase Inhibitors Research', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T12534', 'display_name': 'Protein Degradation and Inhibitors', 'score': 0.9949, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T10269', 'display_name': 'Epigenetics and DNA Methylation', 'score': 0.9937, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/vorinostat', 'display_name': 'Vorinostat', 'score': 0.93748856}, {'id': 'https://openalex.org/keywords/clinical-endpoint', 'display_name': 'Clinical endpoint', 'score': 0.5165638}, {'id': 'https://openalex.org/keywords/refractory', 'display_name': 'Refractory (planetary science)', 'score': 0.42943707}], 'concepts': [{'id': 'https://openalex.org/C2776262904', 'wikidata': 'https://www.wikidata.org/wiki/Q905901', 'display_name': 'Vorinostat', 'level': 5, 'score': 0.93748856}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.8417091}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.5757408}, {'id': 'https://openalex.org/C203092338', 'wikidata': 'https://www.wikidata.org/wiki/Q1340863', 'display_name': 'Clinical endpoint', 'level': 3, 'score': 0.5165638}, {'id': 'https://openalex.org/C90924648', 'wikidata': 'https://www.wikidata.org/wiki/Q120569', 'display_name': 'Gastroenterology', 'level': 1, 'score': 0.5141228}, {'id': 'https://openalex.org/C143998085', 'wikidata': 'https://www.wikidata.org/wiki/Q162555', 'display_name': 'Oncology', 'level': 1, 'score': 0.47975907}, {'id': 'https://openalex.org/C121608353', 'wikidata': 'https://www.wikidata.org/wiki/Q12078', 'display_name': 'Cancer', 'level': 2, 'score': 0.478664}, {'id': 'https://openalex.org/C142424586', 'wikidata': 'https://www.wikidata.org/wiki/Q7307572', 'display_name': 'Refractory (planetary science)', 'level': 2, 'score': 0.42943707}, {'id': 'https://openalex.org/C29730261', 'wikidata': 'https://www.wikidata.org/wiki/Q274160', 'display_name': 'Toxicity', 'level': 2, 'score': 0.42385134}, {'id': 'https://openalex.org/C2778305200', 'wikidata': 'https://www.wikidata.org/wiki/Q174378', 'display_name': 'Histone deacetylase', 'level': 4, 'score': 0.3654441}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.33909482}, {'id': 'https://openalex.org/C535046627', 'wikidata': 'https://www.wikidata.org/wiki/Q30612', 'display_name': 'Clinical trial', 'level': 2, 'score': 0.28909174}, {'id': 'https://openalex.org/C64927066', 'wikidata': 'https://www.wikidata.org/wiki/Q36293', 'display_name': 'Histone', 'level': 3, 'score': 0.12302086}, {'id': 'https://openalex.org/C86803240', 'wikidata': 'https://www.wikidata.org/wiki/Q420', 'display_name': 'Biology', 'level': 0, 'score': 0.0626567}, {'id': 'https://openalex.org/C87355193', 'wikidata': 'https://www.wikidata.org/wiki/Q411', 'display_name': 'Astrobiology', 'level': 1, 'score': 0.0}, {'id': 'https://openalex.org/C55493867', 'wikidata': 'https://www.wikidata.org/wiki/Q7094', 'display_name': 'Biochemistry', 'level': 1, 'score': 0.0}, {'id': 'https://openalex.org/C104317684', 'wikidata': 'https://www.wikidata.org/wiki/Q7187', 'display_name': 'Gene', 'level': 2, 'score': 0.0}], 'mesh': [{'descriptor_ui': 'D000970', 'descriptor_name': 'Antineoplastic Agents', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D001932', 'descriptor_name': 'Brain Neoplasms', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': True}, {'descriptor_ui': 'D005909', 'descriptor_name': 'Glioblastoma', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': True}, {'descriptor_ui': 'D006877', 'descriptor_name': 'Hydroxamic Acids', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D009364', 'descriptor_name': 'Neoplasm Recurrence, Local', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': True}, {'descriptor_ui': 'D000107', 'descriptor_name': 'Acetylation', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000328', 'descriptor_name': 'Adult', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000368', 'descriptor_name': 'Aged', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000970', 'descriptor_name': 'Antineoplastic Agents', 'qualifier_ui': 'Q000493', 'qualifier_name': 'pharmacokinetics', 'is_major_topic': False}, {'descriptor_ui': 'D000970', 'descriptor_name': 'Antineoplastic Agents', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D001932', 'descriptor_name': 'Brain Neoplasms', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': False}, {'descriptor_ui': 'D001932', 'descriptor_name': 'Brain Neoplasms', 'qualifier_ui': 'Q000473', 'qualifier_name': 'pathology', 'is_major_topic': False}, {'descriptor_ui': 'D001932', 'descriptor_name': 'Brain Neoplasms', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D050759', 'descriptor_name': 'Cyclin-Dependent Kinase Inhibitor p21', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': False}, {'descriptor_ui': 'D050759', 'descriptor_name': 'Cyclin-Dependent Kinase Inhibitor p21', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D050760', 'descriptor_name': 'Cyclin-Dependent Kinase Inhibitor p27', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D050760', 'descriptor_name': 'Cyclin-Dependent Kinase Inhibitor p27', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': False}, {'descriptor_ui': 'D019008', 'descriptor_name': 'Drug Resistance, Neoplasm', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D005260', 'descriptor_name': 'Female', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D005500', 'descriptor_name': 'Follow-Up Studies', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D020869', 'descriptor_name': 'Gene Expression Profiling', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D005909', 'descriptor_name': 'Glioblastoma', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': False}, {'descriptor_ui': 'D005909', 'descriptor_name': 'Glioblastoma', 'qualifier_ui': 'Q000473', 'qualifier_name': 'pathology', 'is_major_topic': False}, {'descriptor_ui': 'D005909', 'descriptor_name': 'Glioblastoma', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D056572', 'descriptor_name': 'Histone Deacetylase Inhibitors', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006657', 'descriptor_name': 'Histones', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': False}, {'descriptor_ui': 'D006657', 'descriptor_name': 'Histones', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006877', 'descriptor_name': 'Hydroxamic Acids', 'qualifier_ui': 'Q000493', 'qualifier_name': 'pharmacokinetics', 'is_major_topic': False}, {'descriptor_ui': 'D006877', 'descriptor_name': 'Hydroxamic Acids', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D007124', 'descriptor_name': 'Immunoenzyme Techniques', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008297', 'descriptor_name': 'Male', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008875', 'descriptor_name': 'Middle Aged', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D015394', 'descriptor_name': 'Molecular Structure', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D009364', 'descriptor_name': 'Neoplasm Recurrence, Local', 'qualifier_ui': 'Q000175', 'qualifier_name': 'diagnosis', 'is_major_topic': False}, {'descriptor_ui': 'D009364', 'descriptor_name': 'Neoplasm Recurrence, Local', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D009367', 'descriptor_name': 'Neoplasm Staging', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D011379', 'descriptor_name': 'Prognosis', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D012307', 'descriptor_name': 'Risk Factors', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D015996', 'descriptor_name': 'Survival Rate', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D014018', 'descriptor_name': 'Tissue Distribution', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D016896', 'descriptor_name': 'Treatment Outcome', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000077337', 'descriptor_name': 'Vorinostat', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 4, 'locations': [{'is_oa': True, 'landing_page_url': 'https://doi.org/10.1200/jco.2008.19.0694', 'pdf_url': 'https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2008.19.0694?role=tab', 'source': {'id': 'https://openalex.org/S15137598', 'display_name': 'Journal of Clinical Oncology', 'issn_l': '0732-183X', 'issn': ['0732-183X', '1527-7755'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310315671', 'host_organization_name': 'Lippincott Williams & Wilkins', 'host_organization_lineage': ['https://openalex.org/P4310315671', 'https://openalex.org/P4310318547'], 'host_organization_lineage_names': ['Lippincott Williams & Wilkins', 'Wolters Kluwer'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, {'is_oa': True, 'landing_page_url': 'https://europepmc.org/articles/pmc2669764', 'pdf_url': 'https://europepmc.org/articles/pmc2669764?pdf=render', 'source': {'id': 'https://openalex.org/S4306400806', 'display_name': 'Europe PMC (PubMed Central)', 'issn_l': None, 'issn': None, 'is_oa': True, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1303153112', 'host_organization_name': 'European Bioinformatics Institute', 'host_organization_lineage': ['https://openalex.org/I1303153112'], 'host_organization_lineage_names': ['European Bioinformatics Institute'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, {'is_oa': True, 'landing_page_url': 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2669764', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S2764455111', 'display_name': 'PubMed Central', 'issn_l': None, 'issn': None, 'is_oa': True, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/19307505', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1200/jco.2008.19.0694', 'pdf_url': 'https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2008.19.0694?role=tab', 'source': {'id': 'https://openalex.org/S15137598', 'display_name': 'Journal of Clinical Oncology', 'issn_l': '0732-183X', 'issn': ['0732-183X', '1527-7755'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310315671', 'host_organization_name': 'Lippincott Williams & Wilkins', 'host_organization_lineage': ['https://openalex.org/P4310315671', 'https://openalex.org/P4310318547'], 'host_organization_lineage_names': ['Lippincott Williams & Wilkins', 'Wolters Kluwer'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'sustainable_development_goals': [{'score': 0.81, 'id': 'https://metadata.un.org/sdg/3', 'display_name': 'Good health and well-being'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 23, 'referenced_works': ['https://openalex.org/W1502936039', 'https://openalex.org/W1504303645', 'https://openalex.org/W1935102817', 'https://openalex.org/W1959628099', 'https://openalex.org/W1984254136', 'https://openalex.org/W1985064413', 'https://openalex.org/W2007470097', 'https://openalex.org/W2021577923', 'https://openalex.org/W2022285476', 'https://openalex.org/W2032365508', 'https://openalex.org/W2050969887', 'https://openalex.org/W2084469064', 'https://openalex.org/W2087966689', 'https://openalex.org/W2094979409', 'https://openalex.org/W2096287682', 'https://openalex.org/W2099440961', 'https://openalex.org/W2102428449', 'https://openalex.org/W2114438728', 'https://openalex.org/W2132440338', 'https://openalex.org/W2502670554', 'https://openalex.org/W2570129477', 'https://openalex.org/W2609068367', 'https://openalex.org/W618788809'], 'related_works': ['https://openalex.org/W4200528065', 'https://openalex.org/W3151757475', 'https://openalex.org/W3023264035', 'https://openalex.org/W2516856182', 'https://openalex.org/W2345149559', 'https://openalex.org/W2184344430', 'https://openalex.org/W2145470144', 'https://openalex.org/W1974692834', 'https://openalex.org/W1513102126', 'https://openalex.org/W1483077634'], 'abstract_inverted_index': {'Purpose': [0], 'Vorinostat,': [1], 'a': [2, 7, 39, 46, 53, 181], 'histone': [3, 208], 'deacetylase': [4], 'inhibitor,': [5], 'represents': [6], 'rational': [8], 'therapeutic': [9], 'target': [10, 268], 'in': [11, 72, 94, 121, 173, 180, 195, 217, 223, 242, 262, 270, 276], 'glioblastoma': [12], 'multiforme': [13], '(GBM).': [14], 'Patients': [15, 18], 'and': [16, 76, 84, 98, 111, 176, 200, 206, 247, 255, 265], 'Methods': [17], 'with': [19, 124, 144, 188, 244], 'recurrent': [20, 189, 245], 'GBM': [21, 190, 246], 'who': [22], 'had': [23], 'received': [24], 'one': [25], 'or': [26, 67, 89], 'fewer': [27], 'chemotherapy': [28], 'regimens': [29, 278], 'for': [30, 48], 'progressive': [31], 'disease': [32], 'were': [33, 63], 'eligible.': [34], 'Vorinostat': [35, 237], 'was': [36, 162], 'administered': [37], 'at': [38, 153], 'dose': [40, 264], 'of': [41, 60, 74, 79, 96, 101, 146, 185, 197, 203, 207, 211, 231, 274], '200': [42], 'mg': [43], 'orally': [44], 'twice': [45], 'day': [47], '14': [49], 'days,': [50], 'followed': [51], 'by': [52, 226], '7-day': [54], 'rest': [55], 'period.': [56], 'Results': [57], 'A': [58], 'total': [59], '66': [61], 'patients': [62, 75, 97, 122, 150, 187, 243], 'treated.': [64], 'Grade': [65], '3': [66, 88], 'worse': [68, 90], 'nonhematologic': [69], 'toxicity': [70, 92], 'occurred': [71, 93], '26%': [73, 95], 'consisted': [77, 99], 'mainly': [78, 100], 'fatigue': [80], '(17%),': [81], 'dehydration': [82], '(6%),': [83], 'hypernatremia': [85], '(5%);': [86], 'grade': [87], 'hematologic': [91], 'thrombocytopenia': [102], '(22%).': [103], 'Pharmacokinetic': [104], 'analysis': [105, 171, 216, 254], 'showed': [106, 191, 221], 'lower': [107], 'vorinostat': [108, 261, 275], 'maximum': [109], 'concentration': [110], 'area': [112], 'under': [113], 'the': [114, 137, 147, 218], 'curve': [115], '(0': [116], 'to': [117, 167], '24': [118], 'hours)': [119], 'values': [120], 'treated': [123], 'enzyme-inducing': [125], 'anticonvulsants,': [126], 'although': [127], 'this': [128, 263], 'did': [129], 'not': [130], 'reach': [131], 'statistical': [132], 'significance.': [133], 'The': [134], 'trial': [135], 'met': [136], 'prospectively': [138], 'defined': [139], 'primary': [140], 'efficacy': [141], 'end': [142], 'point,': [143], 'nine': [145], 'first': [148], '52': [149], 'being': [151], 'progression-free': [152], '6': [154], 'months.': [155], 'Median': [156], 'overall': [157], 'survival': [158], 'from': [159], 'study': [160], 'entry': [161], '5.7': [163], 'months': [164], '(range,': [165], '0.7': [166], '28+': [168], 'months).': [169], 'Immunohistochemical': [170], 'performed': [172], 'paired': [174], 'baseline': [175], 'post-vorinostat': [177], 'treatment': [178, 193], 'samples': [179, 220], 'separate': [182], 'surgical': [183], 'subgroup': [184], 'five': [186, 204, 212], 'post': [192], 'increase': [194], 'acetylation': [196, 253], 'histones': [198], 'H2B': [199], 'H4': [201], '(four': [202], 'patients)': [205], 'H3': [209], '(three': [210], 'patients).': [213], 'Microarray': [214], 'RNA': [215, 256], 'same': [219], 'changes': [222], 'genes': [224], 'regulated': [225], 'vorinostat,': [227], 'such': [228], 'as': [229], 'upregulation': [230], 'E-cadherin': [232], '(P': [233], '=': [234], '.02).': [235], 'Conclusion': [236], 'monotherapy': [238], 'is': [239, 279], 'well': [240], 'tolerated': [241], 'has': [248], 'modest': [249], 'single-agent': [250], 'activity.': [251], 'Histone': [252], 'expression': [257], 'profiling': [258], 'indicate': [259], 'that': [260], 'schedule': [266], 'affects': [267], 'pathways': [269], 'GBM.': [271], 'Additional': [272], 'testing': [273], 'combination': [277], 'warranted.': [280]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2171141282', 'counts_by_year': [{'year': 2024, 'cited_by_count': 12}, {'year': 2023, 'cited_by_count': 13}, {'year': 2022, 'cited_by_count': 14}, {'year': 2021, 'cited_by_count': 23}, {'year': 2020, 'cited_by_count': 18}, {'year': 2019, 'cited_by_count': 16}, {'year': 2018, 'cited_by_count': 15}, {'year': 2017, 'cited_by_count': 17}, {'year': 2016, 'cited_by_count': 16}, {'year': 2015, 'cited_by_count': 18}, {'year': 2014, 'cited_by_count': 30}, {'year': 2013, 'cited_by_count': 36}, {'year': 2012, 'cited_by_count': 39}], 'updated_date': '2024-12-09T23:52:11.483790', 'created_date': '2016-06-24'}
Publication Information

Basic Information

Access and Citation

AI Researcher Chatbot

Primary Location

Authors

Topics

Keywords

Related Works
